Spain charges Merck with pharma abuse
Spain’s competition enforcer has accused Merck’s Spanish and EU businesses of anticompetitively hindering the entry of generic hormonal contraceptives.
To read more
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.